Cmpx stock forecast

Top Analyst Stocks Popular.

Disclaimer: This is not investment advice. The information provided is for general information purposes only. No information, materials, services and other content provided on this page constitute a solicitation, recommendation, endorsement, or any financial, investment, or other advice. Seek independent professional consultation in the form of legal, financial, and fiscal advice before making any investment decision. Using the same basis, here is the Compass Therapeutics stock prediction for each year up until This would represent a Based on data from February 25, at , the general CMPX stock forecast sentiment is neutral , with 14 technical analysis indicators signaling bullish signals, and 10 signaling bearish signals.

Cmpx stock forecast

Top Analyst Stocks Popular. Bitcoin Popular. Gold New. Unusual Options Activity Popular. Research Tools. Economic Indicators. Inflation Rate Unemployment Rate. About Us. Working with TipRanks. Follow Us. My Portfolio. My Watchlist. Earnings Calendar. Stock Screener.

Shares Outstanding ,

Compass Therapeutics, Inc. About the company. Analysts in good agreement that stock price will rise by Currently unprofitable and not forecast to become profitable over the next 3 years. Volatile share price over the past 3 months. Ankyra Therapeutics Names Robert V.

View our list of the best stock brokerages. The analyst firm set a price target for 8. Compass Therapeutics is in the Health Care sector and Biotechnology industry. My Account My Account. Benzinga Research. Log In. Our Services. News Earnings.

Cmpx stock forecast

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. ZacksTrade and Zacks. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. OK Cancel. Add to portfolio.

Legacy tattoo studio

Schuetz in and is headquartered in Boston, MA. Does Compass Therapeutics pay dividends? When trying to make a Compass Therapeutics stock forecast, traders also try to identify important support and resistance levels, which can give an indication of when a downtrend is likely to slow down and when an uptrend is likely to stall. These tools can roughly be divided into indicators and chart patterns. Compass Therapeutics, Merck ink collaboration deal for early-stage cancer trial Oct Economic Calendar. CMPX Loses Dividends Dividend Center. Expert Ratings for Compass Therapeutics Jan. ET on TipRanks. No Headlines Available. Get actionable alerts from top Wall Street Analysts.

Compass Therapeutics, Inc. Its product candidates include CTX, in Phase II clinical trials for biliary tract cancers and Phase Ib clinical trial for colorectal and ovarian cancer, and CTX, in Phase I clinical trials for patients with solid tumors small cell lung cancer and melanoma. Compass Therapeutics was founded in and is headquartered in Boston, MA.

Technicals SMA Negative. Compass Therapeutics stock would need to gain 27, Overall Consensus. Updated a minute ago. Analysts in good agreement that stock price will rise by Dividend Stocks. Average Volume 3M Know what industry insiders are buying. Become an Affiliate. Compass Therapeutics has ,, shares outstanding. This is based on the ratings of 2 Wall Streets Analysts. Ownership Overview. Asset Growth Our forecast estimates that CMPX will gain 0.